Aberrant kinase signaling: lessons from head and neck cancer

Author： Nelson Elizabeth G   Grandis Jennifer R  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.3, Iss.3, 2007-06, pp. : 353-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy in Head and Neck Cancer

By Armand J.P.   Couteau C.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 819-822

Elsevier

Access to resources Recommend Favorite

Immunobiology of head and neck cancer

By Whiteside Theresa  

Cancer and Metastasis Reviews, Vol. 24, Iss. 1, 2005-01 ,pp. : 95-105

Springer Publishing Company

Access to resources Recommend Favorite

HEAD AND NECK CANCER

By  

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 32-32

Informa Healthcare

Access to resources Recommend Favorite

Taxanes in head and neck cancer

By Schrijvers Dirk   Vermorken Jan B  

Future Oncology, Vol. 1, Iss. 6, 2005-12 ,pp. : 829-839

Future Medicine

Access to resources Recommend Favorite

Melanoma-associated antigen expression and the efficacy of tyrosine kinase inhibitors in head and neck cancer

By              

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1211-1217

Spandidos Publications

Access to resources Recommend Favorite